Last CNY6.73 CNY
Change Today -0.04 / -0.59%
Volume 13.0M
600664 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

harbin pharmaceutical grp-a (600664) Snapshot

Open
CNY6.77
Previous Close
CNY6.77
Day High
CNY6.78
Day Low
CNY6.68
52 Week High
10/15/13 - CNY7.04
52 Week Low
02/7/14 - CNY5.57
Market Cap
12.9B
Average Volume 10 Days
10.1M
EPS TTM
CNY0.06
Shares Outstanding
1.9B
EX-Date
08/26/14
P/E TM
119.2x
Dividend
CNY0.07
Dividend Yield
--
Current Stock Chart for HARBIN PHARMACEUTICAL GRP-A (600664)

Related News

No related news articles were found.

harbin pharmaceutical grp-a (600664) Related Businessweek News

No Related Businessweek News Found

harbin pharmaceutical grp-a (600664) Details

Harbin Pharmaceutical Group Co., Ltd. is engaged in the research and development, manufacture, and trading of pharmaceutical products. It offers antibiotics, small-molecular drug preparations, OTC and healthcare products, Chinese medicines, biopharmaceuticals, animal vaccines, and medicine circulations. The company’s APIs include penicillin and cephalosporin products, and other pharmaceutical intermediates in various dosage forms, such as injections, injectable powders, oral solutions, tablets, and capsules. The company markets its products primarily to Europe, Asia, Africa, and Middle and North America. Harbin Pharmaceutical Group Co., Ltd. is based in Harbin, China.

harbin pharmaceutical grp-a (600664) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

harbin pharmaceutical grp-a (600664) Key Developments

Harbin Pharmaceutical Group Co., Ltd., Board Meeting, Jun 27, 2014

Harbin Pharmaceutical Group Co., Ltd., Board Meeting, Jun 27, 2014. Agenda: To discuss and approve the proposal of electing chair of seventh directorate; to discuss and approve appointing senior management members; and to discuss and approve the proposal of confirming the members of all the special committees of the directorate.

Harbin Pharmaceutical Group Co., Ltd., Annual General Meeting, Jun 27, 2014

Harbin Pharmaceutical Group Co., Ltd., Annual General Meeting, Jun 27, 2014., at 09:00 China Standard Time. Agenda: To discuss issues including the full text of annual report of 2013 and its abstract; to consider the proposal of scheme of profit distribution in 2013; to consider the proposal of sum-up report on audit work of accounting firm in 2013; and to consider the renewing engagement of its accounting firm.

Harbin Pharmaceutical Group Co., Ltd., Board Meeting, Jun 06, 2014

Harbin Pharmaceutical Group Co., Ltd., Board Meeting, Jun 06, 2014. Agenda: To discuss and approve the proposal of term change of the directorate; and to consider the proposal of convening the annual general meeting of 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600664:CH CNY6.73 CNY -0.04

600664 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China BCT Pharmacy Group Inc $0.03 USD 0.00
Kirin Holdings Co Ltd ¥1,402 JPY +18.00
Roche Holding AG SFr.265.80 CHF +0.30
View Industry Companies
 

Industry Analysis

600664

Industry Average

Valuation 600664 Industry Range
Price/Earnings 100.0x
Price/Sales 0.7x
Price/Book 1.6x
Price/Cash Flow 122.2x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HARBIN PHARMACEUTICAL GRP-A, please visit www.hayao.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.